Bill Sponsor
House Bill 5373
116th Congress(2019-2020)
United States Anti-Doping Agency Reauthorization Act of 2020
Active
Active
Passed House on Sep 29, 2020
Overview
Text
Introduced
Dec 9, 2019
Latest Action
Sep 30, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5373
Congress
116
Policy Area
Sports and Recreation
Sports and Recreation
Primary focus of measure is youth, amateur, and professional athletics; outdoor recreation; sports and recreation facilities. Measures concerning recreation areas may fall under Public Lands and Natural Resources policy area.
Sponsorship by Party
Democrat
California
Democrat
New Hampshire
House Votes (1)
Senate Votes (0)
checkPassed on September 29, 2020
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Summary

United States Anti-Doping Agency Reauthorization Act of 2019

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2027.

The bill also directs (1) USADA to promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration to coordinate with USADA efforts to prevent the use of performance-enhancing drugs or prohibit performance-enhancing methods by sharing all information in their possession that may be relevant to preventing the use of such drugs or prohibiting such methods.

Text (4)
September 30, 2020
September 29, 2020
September 29, 2020
December 9, 2019
Actions (14)
09/30/2020
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
09/29/2020
Motion to reconsider laid on the table Agreed to without objection.
09/29/2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4998)
09/29/2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
09/29/2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 5373.
09/29/2020
Considered under suspension of the rules. (consideration: CR H4998-4999)
09/29/2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
09/29/2020
Placed on the Union Calendar, Calendar No. 448.
09/29/2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-548.
09/09/2020
Ordered to be Reported (Amended) by Voice Vote.
09/09/2020
Committee Consideration and Mark-up Session Held.
12/10/2019
Referred to the Subcommittee on Health.
12/09/2019
Referred to the House Committee on Energy and Commerce.
12/09/2019
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:45:05 PM